At the same time, we can use more advanced and accurate markers for the early diagnosis of AKI in patients to achieve early treatment, such as retinol-binding protein, neutrophil gelatinase associated lipocalin and cystatin C which have been proven sensitive for the early detection of AKI [22, 23]. This evidence concerns the gene LCN2 and acute kidney injury.